Abstract:Although the risk difference (RD) is the most common and well explored functional form for testing efficacy with dichotomous endpoint, odds ratio (OR) is also suggested and well applied measure for non-inferiority (NI) trials. Since the construction and interpretation of these function forms are quite different, this study aims to provide detailed discussions and comprehensive comparisons on the design and testing approach for RD and OR scales for the fixed and group sequential three-arm NI trials under various of situations. The sample size determinations and testing approaches for assessing NI of a new treatment in three-arm clinical trials for RD and OR scales were reviewed comprehensively. Simulation studies are conducted for hundreds of scenarios with parameter configurations of the response rates, randomized allocations, NI margins and interim analysis. The operating characteristic (OC) of RD and OR scales based on the MLE and RMLE methods were thoroughly investigated. A trial example was designed and analyzed to demonstrate the methodologies. It is found that sample size determination on OR scale gives smaller sample size and robust procedure compared to RD scale in the majority of situations. When evaluating the behaviors of the attained power, the RMLE methods based on OR scale outperforms the MLE method and tend to have more power to reject the null hypothesis especially under the small sample size situations. Compared to the fixed design, the group sequential design has better OC, which provides a comparable power while needing smaller total average sample sizes for all cases. In addition, we suggest a lower significance level with a higher power for the sample size determination in the superiority test stage in the group sequential design, which can significantly reduce the total sample sizes while the number of subjects in the placebo group does not increase much. It can offer some recommendations for the investigators to choose the optimal endpoints and parameter configurations to design a three-arm NI trial under certain situations.

Testing Non-Inferiority of a New Treatment in Three-Arm Clinical Trials with Binary Endpoints

Bayesian sample size determination in a three-arm non-inferiority trial with binary endpoints

Tests of Noninferiority Via Rate Difference for Three-Arm Clinical Trials with Placebo.

Semiparametric Bayesian Approach to Assess Non-Inferiority with Assay Sensitivity in a Three-Arm Trial with Normally Distributed Endpoints

Non-Parametric Non-Inferiority Assessment in a Three-Arm Trial with Non-Ignorable Missing Data

Simultaneous Confidence Interval for Assessing Non-Inferiority with Assay Sensitivity in a Three-Arm Trial with Binary Endpoints

A More Efficient Three-Arm Non-Inferiority Test Based on Pooled Estimators of the Homogeneous Variance.

Statistical Analysis of Noninferiority Trials with a Rate Ratio in Small-Sample Matched-Pair Designs.

A framework for testing non-inferiority in a three-arm, sequential, multiple assignment randomized trial

A New Test for Testing Non Inferiority in Matched-Pairs Design.

Two New Methods for Non-Inferiority Testing of the Ratio in Matched-Pair Setting

Simultaneous confidence intervals for an extended Koch-Röhmel design in three-arm non-inferiority trials

Optimization the Design of Fixed and Group Sequential Three-Arm Non-Inferiority Trials with Dichotomous Endpoints of Risk Difference and Odds Ratio

A Direct Approach to Simultaneous Tests of Superiority and Noninferiority with Multiple Endpoints

A Three-Arm Non-Inferiority Test for Heteroscedastic Data

An IM-based Efficient Test for Non Inferiority of the Odds Ratio Between Two Independent Binomial Proportions

On the non-inferiority of a diagnostic test based on paired observations.

Unconditional Exact Tests for Equivalence or Noninferiority for Paired Binary Endpoints

Sample Size Estimation and Hypothesis Testing of Assessing Equivalence/noninferiority for Paired Binary Data

Using non-inferiority test of proportions in design of randomized non-inferiority trials with time-to-event endpoint with a focus on low-event-rate setting

Statistical Methods for Non-inferiority Testing in Active-controlled Clinical Trials